ARS Pharmaceuticals Statistics Share Statistics ARS Pharmaceuticals has 98.21M
shares outstanding. The number of shares has increased by 1.31%
in one year.
Shares Outstanding 98.21M Shares Change (YoY) 1.31% Shares Change (QoQ) 0.1% Owned by Institutions (%) 77.73% Shares Floating 57.7M Failed to Deliver (FTD) Shares 5,683 FTD / Avg. Volume 0.4%
Short Selling Information The latest short interest is 14.86M, so 15.13% of the outstanding
shares have been sold short.
Short Interest 14.86M Short % of Shares Out 15.13% Short % of Float 24.76% Short Ratio (days to cover) 11.88
Valuation Ratios The PE ratio is 127.87 and the forward
PE ratio is -27.36.
ARS Pharmaceuticals's PEG ratio is
-1.12.
PE Ratio 127.87 Forward PE -27.36 PS Ratio 11.47 Forward PS 7.8 PB Ratio 3.98 P/FCF Ratio 78.76 PEG Ratio -1.12
Financial Ratio History Enterprise Valuation ARS Pharmaceuticals has an Enterprise Value (EV) of 971.91M.
EV / Sales 10.9 EV / EBITDA -338.05 EV / EBIT 71.74 EV / FCF 74.85
Financial Position The company has a current ratio of 14.26,
with a Debt / Equity ratio of 0.
Current Ratio 14.26 Quick Ratio 14.04 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is 3.11% and Return on Invested Capital is -0.91%.
Return on Equity 3.11% Return on Assets 2.28% Return on Invested Capital -0.91% Revenue Per Employee $575.15K Profits Per Employee $51.6K Employee Count 155 Asset Turnover 0.25 Inventory Turnover 0.19
Taxes Income Tax 288K Effective Tax Rate 3.48%
Stock Price Statistics The stock price has increased by 50.97% in the
last 52 weeks. The beta is 0.96, so ARS Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.96 52-Week Price Change 50.97% 50-Day Moving Average 16.66 200-Day Moving Average 14 Relative Strength Index (RSI) 50.83 Average Volume (20 Days) 1,413,682
Income Statement In the last 12 months, ARS Pharmaceuticals had revenue of 89.15M
and earned 8M
in profits. Earnings per share was 0.08.
Revenue 89.15M Gross Profit 88.17M Operating Income -3.08M Net Income 8M EBITDA -2.88M EBIT -3.08M Earnings Per Share (EPS) 0.08
Full Income Statement Balance Sheet The company has 50.82M in cash and 42K in
debt, giving a net cash position of 50.77M.
Cash & Cash Equivalents 50.82M Total Debt 42K Net Cash 50.77M Retained Earnings -123.31M Total Assets 327.32M Working Capital 276.24M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 13.55M
and capital expenditures -563K, giving a free cash flow of 12.98M.
Operating Cash Flow 13.55M Capital Expenditures -563K Free Cash Flow 12.98M FCF Per Share 0.13
Full Cash Flow Statement Margins Gross margin is 98.9%, with operating and profit margins of -3.46% and 8.97%.
Gross Margin 98.9% Operating Margin -3.46% Pretax Margin 9.29% Profit Margin 8.97% EBITDA Margin -3.22% EBIT Margin -3.46% FCF Margin 14.57%
